Literature DB >> 17641895

Tender point count and total myalgic score in fibromyalgia: changes over a 28-day period.

J G McVeigh1, M B Finch, D A Hurley, J R Basford, J Sim, G D Baxter.   

Abstract

Tender point count (TPC) is central to fibromyalgia syndrome (FMS), and with total myalgic score (TMS) is often used to monitor the patient's condition. This study aimed to determine the stability of TPC and TMS over time, and to examine how well these measures reflected patients' perceptions of their condition. Twenty-four patients with FMS completed the Fibromyalgia Impact Questionnaire (FIQ) and a visual analogue scale (VAS) measuring well-being, at entrance into the study, and 7 and 28 days later. There was no significant change in TPC (P = 0.074), FIQ score (P = 0.291) or VAS (P = 0.079) of well-being with time. However, mean TMS score did change over time (P = 0.021). There was no correlation between total FIQ score and the other measures (all P-values > 0.05). The significant change in TMS over time may reflect the natural fluctuation in the clinical presentation of FMS.

Entities:  

Mesh:

Year:  2007        PMID: 17641895     DOI: 10.1007/s00296-007-0404-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  33 in total

1.  Quantifying pain threshold and quality of life of fibromyalgia patients.

Authors:  A P Marques; E A G Ferreira; L A Matsutani; C A B Pereira; A Assumpção
Journal:  Clin Rheumatol       Date:  2004-12-23       Impact factor: 2.980

2.  SPA therapy in fibromyalgia: a randomised controlled clinic study.

Authors:  Arif Dönmez; M Zeki Karagülle; Nuran Tercan; Mustafa Dinler; Halim Işsever; Mine Karagülle; Mustafa Turan
Journal:  Rheumatol Int       Date:  2005-06-17       Impact factor: 2.631

3.  Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold.

Authors:  Andrew A Fischer
Journal:  Pain       Date:  1987-07       Impact factor: 6.961

4.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

5.  Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G).

Authors:  M Offenbaecher; M Waltz; P Schoeps
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

6.  The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic.

Authors:  F Wolfe
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

7.  Elements of fibromyalgia in an open population.

Authors:  T Schochat; H Raspe
Journal:  Rheumatology (Oxford)       Date:  2003-03-31       Impact factor: 7.580

8.  Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

Authors:  S Carette; G A McCain; D A Bell; A G Fam
Journal:  Arthritis Rheum       Date:  1986-05

9.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

10.  Population study of tender point counts and pain as evidence of fibromyalgia.

Authors:  P Croft; J Schollum; A Silman
Journal:  BMJ       Date:  1994-09-17
View more
  6 in total

1.  The relationship between tender point count and disease severity in patients with primary fibromyalgia.

Authors:  Ali Salli; Halim Yilmaz; Hatice Ugurlu
Journal:  Rheumatol Int       Date:  2010-07-30       Impact factor: 2.631

2.  Toward characterization and definition of fibromyalgia severity.

Authors:  Stuart Silverman; Alesia Sadosky; Chris Evans; Yating Yeh; Jose Ma J Alvir; Gergana Zlateva
Journal:  BMC Musculoskelet Disord       Date:  2010-04-08       Impact factor: 2.362

3.  Profiles in fibromyalgia: algometry, auditory evoked potentials and clinical characterization of different subtypes.

Authors:  Yolanda Triñanes; Alberto González-Villar; Claudio Gómez-Perretta; María T Carrillo-de-la-Peña
Journal:  Rheumatol Int       Date:  2014-04-11       Impact factor: 2.631

Review 4.  Advances in diagnostic and treatment options in patients with fibromyalgia syndrome.

Authors:  Ali Gur; Pelin Oktayoglu
Journal:  Open Access Rheumatol       Date:  2009-12-09

5.  Reproducibility of tender point examination in chronic low back pain patients as measured by intrarater and inter-rater reliability and agreement: a validation study.

Authors:  Ole Kudsk Jensen; Jacob Callesen; Merete Graakjaer Nielsen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2013-02-26       Impact factor: 2.692

6.  The Relationship between Mechanical Hyperalgesia Assessed by Manual Tender Point Examination and Disease Severity in Patients with Chronic Widespread Pain: A Cross-Sectional Study.

Authors:  Kirstine Amris; Eva Ejlersen Wæhrens; Anders Jespersen; Anders Stockmarr; Robert Bennett; Henning Bliddal; Bente Danneskiold-Samsøe
Journal:  Int J Rheumatol       Date:  2014-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.